A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage

Year 2021, , 322 - 326, 01.04.2021

Bedri Caner Kaya , Yusuf Çekici , Berna Kaya Ahmet Celik Hüseyin Avni Demir , Nurdan Yılmaz

https://doi.org/10.28982/josam.869073

Cited By: 1

Abstract

Background/Aim: Covid-19 is a new coronavirus disease with high mortality that has reached all parts of the world. This study aimed to prospectively compare individual characteristics, echocardiographic findings, and laboratory findings in patients with Covid-19 according to the need for intensive care unit (ICU) admission and mortality.
Methods: In this single-center prospective cohort study, patients hospitalized with the diagnosis of Covid-19 between June and November 2020 were examined in terms of echocardiographic and laboratory results. Early in-hospital findings that might affect mortality, cardiac injury and thrombotic complications were evaluated and compared.
Results: A total of 214 patients who were hospitalized due to Covid-19 were included in our study, 80 (37.3%) of which needed hospitalization in the ICU and 134 (62.6%) of which did not. The mean ages of patients treated in the ICU unit and the ward were 69.5 (57.5-80.5) years and 40 (29-58) years, respectively (P<0.001). Among patients hospitalized in the ICU, mean Troponin T on Day 1 (27.12 ng / L, range: 10.48-70.51, P<0.001), mean Troponin T on Day 3 (31.5ng / L, range: 10.24 - 114.5, P<0.001) and mean D-dimer (2.84ng / L, range: 1.1-8.22, P<0.001) levels of those who died were significantly higher compared to survivors. These parameters were important markers of mortality along with right ventricular end-diastolic diameter (RVDD) (3.3 cm (2.8-3.7) P<001).
Conclusion: While cardiac damage and high D-dimer values suggest the possibility of pulmonary microembolism in those who need ICU hospitalization, the relationship between RVDD and mortality supports the possibility of pulmonary embolism.

Keywords

covid-19, d-dimer, cardiac damage, ICU, RVDD

References

• 1. Nik Muhamad NA, Hawari R, Shafie H. A case report of aluminium phosphide poisoning. Med J Malaysia. 2016;71:213-4.
• 2. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22:32.
• 3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533-4.
• 4. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4.
• 5. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003-8.
• 6. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35:1302-5.
• 7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10.
• 8. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-8.
• 9. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8.
• 10. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42(2):206.
• 11. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv. 2020. doi:10.1101/2020.02.06.20020974
• 12. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60.
• 13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
• 14. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390-1.
• 15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.
• 16. Mercuro NJ, Yen CF, Shim DJ, Maher TR, Mccoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1036-41.
• 17. Barman HA, Atici A, Sahin I, Alici G, Aktas Tekin E, Baycan Ö F, et al. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease. Coron Artery Dis. 2020. doi: 10.1097/MCA.0000000000000914.
• 18. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints. 2020;2020:2020020407.
• 19. Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: An illustrated review. Res Pract Thromb Haemost. 2020;4:744-51.
• 20. Zengin S, Avcı S, Yılmaz S. Clinical and basic cardiovascular features of patients with COVID-19 admitted to a tertiary care center in Turkey. J Surg Med. 2020;4(5):367-70.
• 21. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9.
• 22. Kasper W, Geibel A, Tiede N, Hofmann T, Meinertz T, Just H. [Echocardiography in the diagnosis of lung embolism]. Herz. 1989;14:82-101.
• 23. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020 Apr 19. doi: 10.1016/j.ajem.2020.04.052.